» Articles » PMID: 32967905

A Novel Platform Using RNA Signatures To Accelerate Antimicrobial Susceptibility Testing in Neisseria Gonorrhoeae

Overview
Specialty Microbiology
Date 2020 Sep 24
PMID 32967905
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The rise of antimicrobial-resistant pathogens can be attributed to the lack of a rapid pathogen identification (ID) or antimicrobial susceptibility testing (AST), resulting in delayed therapeutic decisions at the point of care. Gonorrhea is usually empirically treated, with no AST results available before treatment, thus contributing to the rapid rise in drug resistance. Here, we present a rapid AST platform using RNA signatures for Transcriptome sequencing (RNA-seq) followed by bioinformatic tools was applied to explore potential markers in the transcriptome profile of upon minutes of azithromycin exposure. Validation of candidate markers using quantitative real-time PCR (qRT-PCR) showed that two markers ( [NGO1562] and ) can deliver accurate AST results across 14 tested isolates. Further validation of our susceptibility threshold in comparison to MIC across 64 more isolates confirmed the reliability of our platform. Our RNA markers combined with emerging molecular point-of-care systems has the potential to greatly accelerate both ID and AST to inform treatment.

Citing Articles

Rapid Detection of MCR-Mediated Colistin Resistance in Escherichia coli.

Zhang H, Yu F, Lu X, Li Y, Peng D, Wang Z Microbiol Spectr. 2022; 10(3):e0092022.

PMID: 35616398 PMC: 9241874. DOI: 10.1128/spectrum.00920-22.


Bridging the gap between development of point-of-care nucleic acid testing and patient care for sexually transmitted infections.

Hsieh K, Melendez J, Gaydos C, Wang T Lab Chip. 2022; 22(3):476-511.

PMID: 35048928 PMC: 9035340. DOI: 10.1039/d1lc00665g.


Antimicrobial susceptibility testing of Neisseria gonorrhoeae using a phenotypic-molecular assay and lyophilized antimicrobials.

Melendez J, Chen F, Wang T Diagn Microbiol Infect Dis. 2021; 102(2):115590.

PMID: 34871932 PMC: 9241851. DOI: 10.1016/j.diagmicrobio.2021.115590.


Rapid and Accurate Antibiotic Susceptibility Determination of (X)-Positive E. coli Using RNA Biomarkers.

Zhang H, Li Y, Jiang Y, Lu X, Li R, Peng D Microbiol Spectr. 2021; 9(2):e0064821.

PMID: 34704829 PMC: 8549723. DOI: 10.1128/Spectrum.00648-21.


Biographical Feature: Karen C. Carroll, M.D.

Munson E J Clin Microbiol. 2021; 59(8):e0065121.

PMID: 33853837 PMC: 8288278. DOI: 10.1128/JCM.00651-21.

References
1.
Isabella V, Wright L, Barth K, Spence J, Grogan S, Genco C . cis- and trans-acting elements involved in regulation of norB (norZ), the gene encoding nitric oxide reductase in Neisseria gonorrhoeae. Microbiology (Reading). 2008; 154(Pt 1):226-239. DOI: 10.1099/mic.0.2007/010470-0. View

2.
Khazaei T, Barlow J, Schoepp N, Ismagilov R . RNA markers enable phenotypic test of antibiotic susceptibility in Neisseria gonorrhoeae after 10 minutes of ciprofloxacin exposure. Sci Rep. 2018; 8(1):11606. PMC: 6072703. DOI: 10.1038/s41598-018-29707-w. View

3.
Gose S, Kong C, Lee Y, Samuel M, Bauer H, Dixon P . Comparison of Neisseria gonorrhoeae MICs obtained by Etest and agar dilution for ceftriaxone, cefpodoxime, cefixime and azithromycin. J Microbiol Methods. 2014; 95(3):379-80. View

4.
Isabella V, Clark V . Deep sequencing-based analysis of the anaerobic stimulon in Neisseria gonorrhoeae. BMC Genomics. 2011; 12:51. PMC: 3032703. DOI: 10.1186/1471-2164-12-51. View

5.
Zarantonelli L, Borthagaray G, Lee E, Shafer W . Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother. 1999; 43(10):2468-72. PMC: 89502. DOI: 10.1128/AAC.43.10.2468. View